The FDA expects organizations to have full visibility and control over their processes - with shared responsibility for contract manufacturing.

Expectations include;

• Understanding products and processes in order to implement Quality by Design into product development
  
  
• Delivery of Quality Metrics for risk based inspection schedules as proposed by a new quality metrics program
  
  
• Shared responsibility for products manufactured by their CMOs
  
  
• Drive improvements in manufacturing technology, product quality and safety
  

Download this infographic and discover how Life Science organizations have reported 66% improved visibility throughout the organization and an 89% reduction in time spent gathering and aggregating data.

Subscribe to the BIOVIA blog to access articles that explore today's challenges in Discovery, Development, Manufacturing and Quality.